|4Dec 9, 5:19 PM ET

Chen Jing 4

4 · Biostage, Inc. · Filed Dec 9, 2022

Insider Transaction Report

Form 4
Period: 2022-12-07
Chen Jing
Director
Transactions
  • Exercise of In-Money

    Common Stock

    2022-12-07$2.00/sh+174,000$348,000210,000 total
  • Sale

    Common Stock

    2022-12-07$7.17/sh48,532$347,974161,468 total
  • Exercise of In-Money

    Warrants (right to buy)

    2022-12-07174,0000 total
    Exercise: $2.00From: 2017-12-27Exp: 2022-12-27Common Stock (174,000 underlying)
Footnotes (1)
  • [F1]On December 7, 2022, the Reporting Person exercised a warrant to purchase 174,000 shares of common stock for $2 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 48,532 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 125,468 shares of common stock.

Documents

1 file
  • 4
    form4-12092022_101252.xmlPrimary